Invading Your Brain: Clinical marker and genomic database help the diagnoses of glioma patients by Rochester Institute of Technology

Gliomas including glioblastoma multiforme (GBM) are fast-growing, highly aggressive and heterogeneous brain tumor. Poor prognosis making accurate survival prediction and management challenging. Clinical biomarker and genomic mapping have been advancing in recent years, the genomic data generated are extremely important when it comes to diagnosis and choosing appropriate therapy to patient. This 2-page spread reveals one of the most important biomarkers and most prominent mutated genes in glioma, and their specific biological functions to explain why their mutation may lead to glioma.

Cancer genomic data are complex and heterogeneous cancer itself are caused by a lot of possible gene alteration, this data visualization created by Tableau and Adobe Illustrator provides audience basic information of some of the diagnostic indicators, to understand the relationship between biomarkers and gene mutations and brain cancer itself.